Evidence map›Paper›PMID 19601805›Full record

ReviewCurrent molecular medicine2009

Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes.

Vijay Yanamadala, Hideyuki Negoro, Bradley M Denker

Open access · greenAbstract readReview
In one paragraph

Review in Current molecular medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Non-canonical GScientific reports · 2025
    Article
  2. Article
  3. Article
  4. Frontiers in molecular biosciences · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Insights into the Roles of Midazolam in Cancer Therapy.Evidence-based complementary and alternative medicine : eCAM · 2017
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Vijay YanamadalaRenal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Hideyuki Negoro
Bradley M Denker
Brigham and Women's Hospital · US

Funding

Polycystin channels and calciumP50DK074030 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, JING · 2005 to 2009
$5.9M
Attachment, Targeting &Localization of Galpha SubunitsR01GM055223 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DENKER, BRADLEY M · 2002 to 2010
$2.8M
ATTACHMENT, TARGETING &LOCALIZATION OF G ALPHA SUBUNITR29GM055223 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DENKER, BRADLEY M · 1997 to 2001
$237k
NIDDK NIH HHS P50 DK074030NIGMS NIH HHS GM55223NIGMS NIH HHS R01 GM055223NIGMS NIH HHS R29 GM055223
6 · The paper itself

Abstract

Apoptosis, a programmed cell death mechanism, is a fundamental process during the normal development and somatic maintenance of all multicellular organisms and thus is highly conserved and tightly regulated through numerous signaling pathways. Apoptosis is of particular clinical importance as its dysregulation contributes significantly to numerous human diseases, primarily through changes in the expression and activation of key apoptotic regulators. Each of the four families of heterotrimeric G proteins (G(s), G(i/o), G(q/11) and G(12/13)) has been implicated in numerous cellular signaling processes, including proliferation, transformation, migration, differentiation, and apoptosis. Heterotrimeric G protein signaling is an important but not widely studied mechanism regulating apoptosis. G protein Signaling and Apoptosis broadly cover two large bodies of literature and share numerous signaling pathways. Examination of the intersection between these two areas is the focus of this review. Several studies have implicated signaling through each of the four heterotrimeric G protein families to regulate apoptosis within numerous disease contexts, but the mechanism(s) are not well defined. Each G protein family has been shown to stimulate and/or inhibit apoptosis in a context-dependent fashion through regulating numerous downstream effectors including the Bcl-2 family, NF-kappaB, PI3 Kinase, MAP Kinases, and small GTPases. These cell-type specific and G protein coupled receptor dependent effects have led to a complex body of literature of G protein regulation of apoptosis. Here, we review the literature and summarize apoptotic signaling through each of the four heterotrimeric G protein families (and the relevant G protein coupled receptors), and discuss limitations and future directions for research on regulating apoptosis through G protein coupled mechanisms. Continued investigation in this field is essential for the identification of important targets for pharmacological intervention in numerous diseases.

Indexed as

AnimalsApoptosisCaspasesHeterotrimeric GTP-Binding ProteinsHumansMitogen-Activated Protein KinasesModels, BiologicalPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-bcl-2Signal TransductionCaspasesHeterotrimeric GTP-Binding ProteinsMitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-bcl-2

Identifiers

PMID19601805
PMCPMC2822437
OpenAlexW2163725076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.